Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage

Stroke

Volumn 42, Issue 11, 2011, Pages 3067-3074

  Selim, Magdy ^a   Yeatts, Sharon ^b   Goldstein, Joshua N ^c   Gomes, Joao ^d   Greenberg, Steven ^c   Morgenstern, Lewis B ^e   Schlaug, Gottfried ^a   Torbey, Michel ^f   Waldman, Bonnie ^b   Xi, Guohua ^e   Palesch, Yuko ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

deferoxamine mesylate; ICH; iron

Indexed keywords

DEFEROXAMINE MESYLATE;

ADULT; AGED; ARM PAIN; ARTICLE; ASPIRATION PNEUMONIA; BLOOD PRESSURE; BLURRED VISION; BRAIN HEMORRHAGE; BRAIN STEM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INJECTION SITE IRRITATION; INTRAVENOUS INFILTRATION; KIDNEY FAILURE; LUNG EMBOLISM; MALE; MAXIMUM TOLERATED DOSE; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NEUROLOGIC DISEASE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RANKIN SCALE; RASH; SCORING SYSTEM; SHOULDER PAIN; SIDE EFFECT; TREATMENT OUTCOME; VISUAL HALLUCINATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; COHORT STUDIES; DEFEROXAMINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTENSION; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED;

EID: 80055001133     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.617589     Document Type: Article

References (33)

1. Goldstein L, Teng ZP, Zeserson E, Patel M, Regan RF. Hemin induces an iron-dependent, oxidative injury to human neuron-like cells. J Neurosci Res. 2003;73:113-121. (Pubitemid 36791376)
2. Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg. 2002;96:287-293. (Pubitemid 34230243)
3. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G. Iron and ironhandling proteins in the brain after intracerebral hemorrhage. Stroke. 2003;34:2964-2969. (Pubitemid 37517778)
4. He Y, Wan S, Hua Y, Keep RF, Xi G. Autophagy after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab. 2008;28:897-905. (Pubitemid 351589625)
5. Regan RF, Panter SS. Hemoglobin potentiates excitotoxic injury in cortical cell culture. J Neurotrauma. 1996;13:223-2231.
6. Nakamura T, Keep RF, Hua Y, Hoff JT, Xi G. Oxidative DNA injury after experimental intracerebral hemorrhage. Brain Res. 2005;1039: 30-36. (Pubitemid 40386824)
7. Chen M, Olatilewa O. Awe, Jing Chen-Roetling Raymond F. Regan. Iron regulatory protein-2 knockout increases perihematomal ferritin expression and cell viability after intracerebral hemorrhage. Brain Research. 2010;1337:95-103.
8. Winterbourn CC. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol Lett. 1995;82-83:969-974. (Pubitemid 26054777)
9. Selim M. Deferoxamine mesylate: A new hope for intracerebral hemorrhage: from bench to clinical trials. Stroke. 2009;40:S90-S91.
10. Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G. Deferoxamine- induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg. 2004;100:672-678. (Pubitemid 38372849)
11. Tanji K, Imaizumi T, Matsumiya T, Itaya H, Fujimoto K, Cui X, et al. Desferrioxamine, an iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line. Biochim Biophys Acta. 2001;1530:227-235. (Pubitemid 32182432)
12. Ratan RR, Siddiq A, Aminova L, Langley B, McConoughey S, Karpisheva K, et al. Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury. Ann N Y Acad Sci. 2008;1147:383-394.
13. Okauchi M, Hua Y, Keep RF, Morgenstern LB, Xi G. Effect of deferoxamine on intracerebral hemorrhage-induced injury in aged rats. Stroke. 2009;40:1858-1863.
14. Gu Y, Hua Y, Keep RF, Morgenstern LB, Xi G. Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke. 2009;40:2241-2243.
15. Okauchi M, Hua Y, Keep RF, Morgenstern LB, Schallert T, Xi G. Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke. 2010;41:375-382.
16. Piantadosi S, Fisher JD, Grossman S. Practical implementation of a modified continual reassessment method for dose-finding trials. Cancer Chemother Pharmacol. 1998;41:429-436. (Pubitemid 28140705)
17. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al. American Heart Association/American Stroke Association Stroke Council; American Heart Association/American Stroke Association High Blood Pressure Research Council; Quality of Care and Outcomes in Research Interdisciplinary Working Group. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38:2001-2023. (Pubitemid 46850654)
18. Gebel JM Jr, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke. 2002;33:2631-2635. (Pubitemid 35266434)
19. Mehdiratta M, Kumar S, Hackney D, Schlaug G, Selim M. Association between serum ferritin level and perihematoma edema volume in patients with spontaneous intracerebral hemorrhage. Stroke. 2008;39: 1165-1170. (Pubitemid 351440686)
20. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer M, et al. The FAST trial investigators. Efficacy and safety of recombinant activated factor VII for acute ICH. N Engl J Med. 2008;358:2127-2137. (Pubitemid 351679599)
21. Lyden PD, Shuaib A, Lees KR, Davalos A, Davis SM, Diener HC, et al. CHANT Trial Investigators. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke. 2007;38: 2262-2269. (Pubitemid 47457566)
22. Haley EC Jr, Thompson JL, Levin B, Davis S, Lees KR, Pittman JG, et al. GAIN Americas and GAIN International Investigators. Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies. Stroke. 2005;36:1006-1010. (Pubitemid 40629293)
23. PDR Health. Physicians Desk Reference. http://www.pdr.net/search/ searchResult.aspx?searchCriteria-deferoxamine-mesylate. Accessed May 3, 2011.
24. Macdonald RL, Marton LS, Andrus PK, Hall ED, Johns L, Sajdak M. Time course of production of hydroxyl free radical after subarachnoid hemorrhage in dogs. Life Sci. 2004;75:979-989. (Pubitemid 38749257)
25. Perez de la Ossa N, Sobrino T, Silva Y, Blanco M, Millan M, Gomis M, Agulla J, et al. Iron-related brain damage in patients with intracerebral hemorrhage. Stroke. 2010;41:810-813.
26. Lou M, Lieb K, Selim M. The relationship between hematoma iron content and perihematoma edema: an MRI study. Cerebrovasc Dis. 2009; 27:266-271.
27. Suri MF, Suarez JI, Rodrigue TC, Zaidat OO, Vazquez G, Wensel A, et al. Effect of treatment of elevated blood pressure on neurological deterioration in patients with acute intracerebral hemorrhage. Neurocrit Care. 2008;9:177-182.
28. Baynes R, Bezwoda W, Bothwell T, Khan Q, Mansoor N. The nonimmune inflammatory response: serial changes in plasma iron, iron binding capacity, lactoferrin, ferritin and C-reactive protein. Scand J Clin Lab Invest. 1986;46:695-704. (Pubitemid 17171522)
29. Inaji M, Tomita H, Tone O, Tamaki M, Suzuki R, Ohno K. Chronological changes of perihematomal edema of human intracerebral hematoma. Acta Neurochir Suppl. 2003;86:445-448.
30. Wu G, Xi G, Huang F. Spontaneous intracerebral hemorrhage in humans: Hematoma enlargement, clot lysis, and brain edema. Acta Neurochir. 2006 (supplement) 96;78-80.
31. Venkatasubramanian C, Mlynash M, Finley-Caulfield A, Eyngorn I, Kalimuthu R, Snider RW, et al. Natural history of perihematomal edema after intracerebral hemorrhage measured by serial magnetic resonance imaging. Stroke. 2011;42:73-80.
32. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ. Progression of mass effect after intracerebral hemorrhage. Stroke. 1999;30:1167-1173. (Pubitemid 29259168)
33. McCarron MO, Hoffmann KL, DeLong DM, Gray L, Saunders AM, Alberts MJ. Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes. Neurology. 1999;53: 2176-2179.